Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLDOPA for Foetal exposure during pregnancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 206 adverse event reports in the FDA FAERS database where METHYLDOPA was used for Foetal exposure during pregnancy.

Most Reported Side Effects for METHYLDOPA

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 1,028 39.5% 48 156
Premature baby 792 30.4% 21 156
Maternal exposure during pregnancy 623 23.9% 3 237
Premature delivery 519 19.9% 1 156
Exposure during pregnancy 502 19.3% 5 155
Low birth weight baby 350 13.4% 14 75
Foetal growth restriction 172 6.6% 9 53
Drug ineffective 162 6.2% 1 80
Live birth 153 5.9% 0 100
Off label use 152 5.8% 1 58
Pre-eclampsia 110 4.2% 0 64
Atrial septal defect 104 4.0% 1 8
Dyspnoea 93 3.6% 0 67
Hypertension 85 3.3% 2 56
Small for dates baby 80 3.1% 0 4

Other Indications for METHYLDOPA

Hypertension (954) Product used for unknown indication (813) Gestational hypertension (87) Pre-eclampsia (77) Essential hypertension (43) Blood pressure increased (33) Renal hypertension (26) Blood pressure management (23) Blood pressure measurement (19) Drug therapy (17)

Other Drugs Used for Foetal exposure during pregnancy

HYDROXYPROGESTERONE CAPROATE (4,042) ONDANSETRON (1,061) ASPIRIN (485) BETAMETHASONE (475) PREDNISONE (429) ACETAMINOPHEN (428) OXYCODONE (414) LEVETIRACETAM (401) TACROLIMUS (382) LAMOTRIGINE (343)

Related Pages

METHYLDOPA Full Profile All Foetal exposure during pregnancy Drugs METHYLDOPA Demographics METHYLDOPA Timeline